InvestorsHub Logo
Followers 21
Posts 3561
Boards Moderated 0
Alias Born 12/18/2019

Re: moneycrew post# 198101

Friday, 12/24/2021 11:58:46 PM

Friday, December 24, 2021 11:58:46 PM

Post# of 232880
Competitive clinical data being compared to LL data is factual information.

Haven't seen any evidence that Cytodyn will have any real competitive position. If Cytodyn can get a BLA approved, they still have Vyera for commercialization -- there is no way that Vyera has the capability to compete with Gilead's massive, effective sales force.

NASH and mTNBC will take years to conclude a clinical trial program.

It would take another decade, and so many thing to go right for Cytodyn to even compete with medium sized biotechs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News